{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:59:28Z","timestamp":1785401968816,"version":"3.56.0"},"reference-count":330,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res Clin Pract"],"published-print":{"date-parts":[[2026,3,24]]},"abstract":"<jats:p>Hypersensitivity pneumonitis (HP) is an interstitial lung disease triggered by inhalation\nof a variety of environmental antigens. HP ranges from acute manifestations to\nprogressive fibrosis and can be classified as nonfibrotic or fibrotic based on imaging\nand histopathological features. The pathophysiological mechanism of HP involves an\nexaggerated immune cell response and, in chronic stages, fibroblast activation leading to\nfibrosis. Diagnosis requires integrated assessment of exposure history, HRCT findings,\nBAL findings, and histopathological findings, as well as multidisciplinary discussion.\nIn nonfibrotic HP patients, HRCT typically shows ground-glass opacities, centrilobular\nnodules, and mosaic attenuation, whereas, in fibrotic HP patients, HRCT often shows\nreticulation, traction bronchiectasis, and honeycombing. Typical histological features\ninclude cellular bronchiolitis, poorly formed granulomas, and interstitial fibrosis. Recent\nadvances in imaging\u2014including artificial intelligence\u2013based pattern recognition\u2014and\ninvestigation of biomarkers are improving precision and will likely contribute to the\ndiagnostic investigation of HP. Management strategies depend on disease phenotype and\nseverity, with antigen avoidance remaining the cornerstone of therapy. Immunomodulators\nsuch as corticosteroids, azathioprine, and mycophenolate may be used when there is\nevidence or suspicion of active inflammatory disease, whereas nintedanib is indicated\nfor progressive fibrotic forms. Emerging phosphodiesterase 4B inhibitors have shown\npromise based on recent evidence. A greater number of comorbidities are observed in\npatients with fibrotic HP and are associated with worse survival, particularly pulmonary\nhypertension. Understanding genetic predisposition, comorbidities, and the transition\nfrom inflammation to fibrosis is essential to guide personalized treatment and improve\noutcomes. This review provides an update of pathophysiology, current diagnostic\napproaches, and therapeutic options, including emerging strategies.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250394","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:40:18Z","timestamp":1774464018000},"page":"e20250394","source":"Crossref","is-referenced-by-count":0,"title":["Current concepts in the diagnosis and treatment of hypersensitivity pneumonitis: a narrative review"],"prefix":"10.36416","author":[{"given":"Guilherme","family":"das Posses Bridi1,2","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00q3jak84","id-type":"ROR","asserted-by":"publisher"}],"name":"Instituto do Cora\u00e7\u00e3o - HCFMUSP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Maggioni Holz1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00q3jak84","id-type":"ROR","asserted-by":"publisher"}],"name":"Instituto do Cora\u00e7\u00e3o - HCFMUSP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Eiji Arimura1,3","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00q3jak84","id-type":"ROR","asserted-by":"publisher"}],"name":"Instituto do Cora\u00e7\u00e3o - HCFMUSP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Caroline Toledo do Nascimento4","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Valente Yamada Sawamura5,6","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03r5mk904","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital S\u00edrio-Liban\u00eas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo","family":"Adib Kairalla1,6","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03r5mk904","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital S\u00edrio-Liban\u00eas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Guedes Baldi1,7","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04dzaw261","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital do Cora\u00e7\u00e3o"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"ref0","unstructured":"REFERENCES"},{"key":"ref1","unstructured":"1. Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M,"},{"key":"ref2","unstructured":"Vasakova M, et al. Diagnosis of Hypersensitivity Pneumonitis in"},{"key":"ref3","unstructured":"Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline. Am J"},{"key":"ref4","unstructured":"Respir Crit Care Med. 2020;202(3):e36-e69. https:\/\/doi.org\/10.1164\/"},{"key":"ref5","unstructured":"rccm.202005-2032ST"},{"key":"ref6","unstructured":"2. Fern\u00e1ndez P\u00e9rez ER, Travis WD, Lynch DA, Brown KK, Johannson"},{"key":"ref7","unstructured":"KA, Selman M, et al. Diagnosis and Evaluation of Hypersensitivity"},{"key":"ref8","unstructured":"Pneumonitis: CHEST Guideline and Expert Panel Report. Chest."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"2021;160(2):e97-e156. https:\/\/doi.org\/10.1016\/j.chest.2021.03.066","DOI":"10.1016\/j.chest.2021.03.066"},{"key":"ref10","unstructured":"3. Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et"},{"key":"ref11","unstructured":"al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"N Engl J Med. 2019;381(18):1718-1727. https:\/\/doi.org\/10.1056\/","DOI":"10.1056\/NEJMoa1908681"},{"key":"ref13","unstructured":"NEJMoa1908681"},{"key":"ref14","unstructured":"4. George PM, Spagnolo P, Kreuter M, Altinisik G, Bonifazi M, Martinez"},{"key":"ref15","unstructured":"FJ, et al. Progressive fibrosing interstitial lung disease: clinical"},{"key":"ref16","unstructured":"uncertainties, consensus recommendations, and research priorities."},{"key":"ref17","unstructured":"Lancet Respir Med. 2020;8(9):925-934. https:\/\/doi.org\/10.1016\/"},{"key":"ref18","unstructured":"S2213-2600(20)30355-6"},{"key":"ref19","unstructured":"5. Costabel U, Miyazaki Y, Pardo A, Koschel D, Bonella F, Spagnolo P, et"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"al. Hypersensitivity pneumonitis. Nat Rev Dis Primers. 2020;6(1):65.","DOI":"10.1038\/s41572-020-0207-8"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41572-020-0191-z","DOI":"10.1038\/s41572-020-0191-z"},{"key":"ref22","unstructured":"6. Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina"},{"key":"ref23","unstructured":"M, Raghu G. Hypersensitivity Pneumonitis: Current Concepts of"},{"key":"ref24","unstructured":"Pathogenesis and Potential Targets for Treatment. Am J Respir"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Crit Care Med. 2019;200(3):301-308. https:\/\/doi.org\/10.1164\/","DOI":"10.21037\/jeccm.2019.02.01"},{"key":"ref26","unstructured":"rccm.201903-0541PP"},{"key":"ref27","unstructured":"7. Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis:"},{"key":"ref28","unstructured":"insights in diagnosis and pathobiology. Am J Respir Crit Care Med."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"2012;186(4):314-24. https:\/\/doi.org\/10.1164\/rccm.201203-0513CI","DOI":"10.1164\/rccm.201203-0513CI"},{"key":"ref30","unstructured":"8. Fern\u00e1ndez P\u00e9rez ER, Swigris JJ, Forss\u00e9n AV, Tourin O, Solomon"},{"key":"ref31","unstructured":"JJ, Huie TJ, et al. Identifying an inciting antigen is associated"},{"key":"ref32","unstructured":"with improved survival in patients with chronic hypersensitivity"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"pneumonitis. Chest. 2013;144(5):1644-1651. https:\/\/doi.org\/10.1378\/","DOI":"10.1378\/chest.12-2685"},{"key":"ref34","unstructured":"chest.12-2685"},{"key":"ref35","unstructured":"9. Anwar J, Kong WT, Balakrishnan B. Updates in Hypersensitivity"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Pneumonitis: A Narrative Review. Curr Pulmonol Rep. 2022;11:106-","DOI":"10.1007\/s13665-022-00294-6"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"115. https:\/\/doi.org\/10.1007\/s13665-022-00294-6","DOI":"10.1007\/s13665-022-00294-6"},{"key":"ref38","unstructured":"10. Spagnolo P, Guler SA, Chaudhuri N, Udwadia Z, Ses\u00e9 L, Kaul B, et al."},{"key":"ref39","unstructured":"Global epidemiology and burden of interstitial lung disease. Lancet"},{"key":"ref40","unstructured":"Respir Med. 2025;13(8):739-755. https:\/\/doi.org\/10.1016\/S2213-"},{"key":"ref41","unstructured":"2600(25)00129-8"},{"key":"ref42","unstructured":"11. Fern\u00e1ndez P\u00e9rez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni"},{"key":"ref43","unstructured":"R, Cole AL. Epidemiology of Hypersensitivity Pneumonitis among"},{"key":"ref44","unstructured":"an Insured Population in the United States: A Claims-based Cohort"},{"key":"ref45","unstructured":"Analysis. Ann Am Thorac Soc. 2018;15(4):460-469. https:\/\/doi."},{"key":"ref46","unstructured":"org\/10.1513\/AnnalsATS.201704-288OC"},{"key":"ref47","unstructured":"12. Solaymani-Dodaran M, West J, Smith C, Hubbard R. Extrinsic allergic"},{"key":"ref48","unstructured":"alveolitis: incidence and mortality in the general population. QJM"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"2007;100,(4):233-7. https:\/\/doi.org\/10.1093\/qjmed\/hcm008","DOI":"10.1093\/qjmed\/hcm008"},{"key":"ref50","unstructured":"13. Xaubet A, Ancochea J, Morell F, Rodriguez-Arias JM, Villena V,"},{"key":"ref51","unstructured":"Blanquer R, et al. Report on the incidence of interstitial lung diseases"},{"key":"ref52","unstructured":"in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(1):64-70."},{"key":"ref53","unstructured":"14. Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, et al."},{"key":"ref54","unstructured":"Interstitial Lung Disease in India. Results of a Prospective Registry."},{"key":"ref55","unstructured":"Am J Respir Crit Care Med. 2017;195(6):801-813. https:\/\/doi."},{"key":"ref56","unstructured":"org\/10.1164\/rccm.201607-1484OC"},{"key":"ref57","unstructured":"15. Morell F, Villar A, Montero M\u00c1, Mu\u00f1oz X, Colby TV, Pipvath S, et"},{"key":"ref58","unstructured":"al. Chronic hypersensitivity pneumonitis in patients diagnosed with"},{"key":"ref59","unstructured":"idiopathic pulmonary fibrosis: a prospective case-cohort study."},{"key":"ref60","unstructured":"Lancet Respir Med. 2013;1(9):685-94. https:\/\/doi.org\/10.1016\/S2213-"},{"key":"ref61","unstructured":"2600(13)70191-7"},{"key":"ref62","unstructured":"16. Zhang X, Igor B, Elena D, Olga R, Glazachev O. Prevalence of"},{"key":"ref63","unstructured":"occupational hypersensitivity pneumonitis: a systematic review and"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"meta-analysis. Int J Environ Health Res. 2024;34(11):3891-3908.","DOI":"10.1080\/09603123.2024.2333021"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/09603123.2024.2333021","DOI":"10.1080\/09603123.2024.2333021"},{"key":"ref66","unstructured":"17. Matias SLK, Pereira CAC, Soares MR, Fernandes FCV, Moreira"},{"key":"ref67","unstructured":"MAC, Baptista FMA, et al. Relative incidence of interstitial lung"},{"key":"ref68","unstructured":"diseases in Brazil. J Bras Pneumol. 2024;50(1):e20230232. https:\/\/"},{"key":"ref69","unstructured":"doi.org\/10.36416\/1806-3756\/e20230232"},{"key":"ref70","unstructured":"18. Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity"},{"key":"ref71","unstructured":"Pneumonitis: Perspectives in Diagnosis and Management. Am J"},{"key":"ref72","unstructured":"Respir Crit Care Med. 2017;196(6):680-689. https:\/\/doi.org\/10.1164\/"},{"key":"ref73","unstructured":"rccm.201611-2201PP"},{"key":"ref74","unstructured":"19. Pereira CAC, Soares MR, Boaventura R, Castro MDC, Gomes"},{"key":"ref75","unstructured":"PS, Gimenez A, et al. Squawks in interstitial lung disease"},{"key":"ref76","unstructured":"prevalence and causes in a cohort of one thousand patients."},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Medicine (Baltimore). 2019;98(29):e16419. https:\/\/doi.org\/10.1097\/","DOI":"10.1097\/MD.0000000000016419"},{"key":"ref78","unstructured":"MD.0000000000016419"},{"key":"ref79","unstructured":"20. Trushenko NV, Suvorova OA, Nekludova GV, Levina IA, Chikina"},{"key":"ref80","unstructured":"SY, Nikolenko AM, et al. Predictors of Pulmonary Hypertension"},{"key":"ref81","unstructured":"and Right Ventricular Dysfunction in Patients with Hypersensitivity"},{"key":"ref82","unstructured":"Pneumonitis. Life (Basel). 2023;13(6):1348. https:\/\/doi.org\/10.3390\/"},{"key":"ref83","unstructured":"life13061348"},{"key":"ref84","unstructured":"21. Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR,"},{"key":"ref85","unstructured":"Walsh SLF, et al. Identification of Diagnostic Criteria for Chronic"},{"key":"ref86","unstructured":"Hypersensitivity Pneumonitis: An International Modified Delphi"},{"key":"ref87","unstructured":"Survey. Am J Respir Crit Care Med. 2018;197(8):1036-1044. https:\/\/"},{"key":"ref88","unstructured":"doi.org\/10.1164\/rccm.201712-2403ED"},{"key":"ref89","unstructured":"22. Hill M, Petnak T, Moua T. Bronchoalveolar lavage lymphocytosis in"},{"key":"ref90","unstructured":"hypersensitivity pneumonitis: a retrospective cohort analysis with"},{"key":"ref91","unstructured":"elimination of incorporation bias. BMC Pulm Med. 2022;22(1):49."},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12890-022-01844-z","DOI":"10.1186\/s12890-022-01844-z"},{"key":"ref93","unstructured":"23. Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M,"},{"key":"ref94","unstructured":"et al. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are"},{"key":"ref95","unstructured":"Associated With Distinct Survival Time and Pulmonary Function"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Trajectory. Chest. 2019;155(4):699-711. https:\/\/doi.org\/10.1016\/j.","DOI":"10.1016\/j.chest.2018.08.1076"},{"key":"ref97","unstructured":"chest.2018.08.1076"},{"key":"ref98","unstructured":"24. Petnak T, Thongprayoon C, Baqir M, Ryu JH, Moua T. Antigen"},{"key":"ref99","unstructured":"identification and avoidance on outcomes in fibrotic hypersensitivity"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"pneumonitis. Eur Respir J. 2022;60(4):2101336. https:\/\/doi.","DOI":"10.1183\/13993003.01336-2021"},{"key":"ref101","unstructured":"org\/10.1183\/13993003.01336-2021"},{"key":"ref102","unstructured":"25. Grant-Orser A, Asmussen M, Marinescu DC, Hague CJ, Muller"},{"key":"ref103","unstructured":"NL, Murphy DT, et al. BAL Fluid Cellular Analysis and Radiologic"},{"key":"ref104","unstructured":"Patterns in Patients With Fibrotic Interstitial Lung Disease. Chest."},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"2025;167(1):172-182. https:\/\/doi.org\/10.1016\/j.chest.2024.07.166","DOI":"10.1016\/j.chest.2024.07.166"},{"key":"ref106","unstructured":"26. Fern\u00e1ndez P\u00e9rez ER, Swigris JJ, Forss\u00e9n AV, Tourin O, Solomon"},{"key":"ref107","unstructured":"JJ, Huie TJ, et al. Identifying an inciting antigen is associated"},{"key":"ref108","unstructured":"with improved survival in patients with chronic hypersensitivity"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"pneumonitis. Chest. 2013;144(5):1644-1651. https:\/\/doi.org\/10.1378\/","DOI":"10.1378\/chest.12-2685"},{"key":"ref110","unstructured":"chest.12-2685"},{"key":"ref111","unstructured":"27. Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira"},{"key":"ref112","unstructured":"CAC. Change in FVC and survival in chronic fibrotic hypersensitivity"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"pneumonitis. Thorax. 2018;73(4):391-392. https:\/\/doi.org\/10.1136\/","DOI":"10.1136\/thoraxjnl-2017-210035"},{"key":"ref114","unstructured":"thoraxjnl-2017-210035"},{"key":"ref115","unstructured":"28. Walsh SL, Sverzellati N, Devaraj A, Wells AU, Hansell DM.. Chronic"},{"key":"ref116","unstructured":"hypersensitivity pneumonitis: high resolution computed tomography"},{"key":"ref117","unstructured":"patterns and pulmonary function indices as prognostic determinants."},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Eur Radiol 2012;22(8):1672-1679 https:\/\/doi.org\/10.1007\/s00330-","DOI":"10.1007\/s00330-012-2427-0"},{"key":"ref119","unstructured":"012-2427-0"},{"key":"ref120","unstructured":"29. Adegunsoye A, Oldham JM, Bellam SK, Montner S, Churpek MM,"},{"key":"ref121","unstructured":"Noth I, et al. Computed tomography honeycombing identifies a"},{"key":"ref122","unstructured":"progressive fibrotic phenotype with increased mortality across"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"diverse interstitial lung diseases. Ann Am Thorac Soc. 2019;16(5):580-","DOI":"10.1513\/AnnalsATS.201807-443OC"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"588. https:\/\/doi.org\/10.1513\/AnnalsATS.201807-443OC","DOI":"10.1513\/AnnalsATS.201807-443OC"},{"key":"ref125","unstructured":"30. Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M,"},{"key":"ref126","unstructured":"et al. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are"},{"key":"ref127","unstructured":"Associated With Distinct Survival Time and Pulmonary Function"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Trajectory. Chest. 2019;155(4):699-711. https:\/\/doi.org\/10.1016\/j.","DOI":"10.1016\/j.chest.2018.08.1076"},{"key":"ref129","unstructured":"chest.2018.08.1076"},{"key":"ref130","unstructured":"31. Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper"},{"key":"ref131","unstructured":"WA, et al. Cryobiopsy versus Open Lung biopsy in the Diagnosis of"},{"key":"ref132","unstructured":"Interstitial lung disease alliance (COLDICE) Investigators. Diagnostic"},{"key":"ref133","unstructured":"accuracy of transbronchial lung cryobiopsy for interstitial lung disease"},{"key":"ref134","unstructured":"diagnosis (COLDICE): a prospective, comparative study. Lancet"},{"key":"ref135","unstructured":"Respir Med. 2020;8(2):171-181. https:\/\/doi.org\/10.1183\/13993003."},{"key":"ref136","unstructured":"congress-2019.RCT1886"},{"key":"ref137","unstructured":"32. Barnes H, Johannson KA. Management of Fibrotic Hypersensitivity"},{"key":"ref138","doi-asserted-by":"crossref","unstructured":"Pneumonitis. Clin Chest Med. 2021;42(2):311-319. https:\/\/doi.","DOI":"10.1016\/j.ccm.2021.03.007"},{"key":"ref139","unstructured":"org\/10.1016\/j.ccm.2021.03.007"},{"key":"ref140","unstructured":"33. Hamblin M, Prosch H, Va\u0161\u00e1kov\u00e1 M. Diagnosis, course and"},{"key":"ref141","unstructured":"management of hypersensitivity pneumonitis. Eur Respir Rev."},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"2022;31(163):210169. https:\/\/doi.org\/10.1183\/16000617.0169-2021","DOI":"10.1183\/16000617.0169-2021"},{"key":"ref143","unstructured":"34. Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson"},{"key":"ref144","unstructured":"KA, et al. Pathologic findings and prognosis in a large prospective"},{"key":"ref145","unstructured":"cohort of chronic hypersensitivity pneumonitis. Chest 2017;"},{"key":"ref146","doi-asserted-by":"crossref","unstructured":"152(3):502-509. https:\/\/doi.org\/10.1016\/j.chest.2017.02.011","DOI":"10.1016\/j.chest.2017.02.011"},{"key":"ref147","unstructured":"35. Ryerson CJ, Marinescu DC, Muller NL, Hague CJ, Murphy D,"},{"key":"ref148","unstructured":"Churg A, et al. Outcomes of a Typical Fibrotic Hypersensitivity"},{"key":"ref149","unstructured":"Pneumonitis Pattern on Chest Computed Tomography. Am J Respir"},{"key":"ref150","unstructured":"Crit Care Med. 2025;211(10):1802-1810. https:\/\/doi.org\/10.1164\/"},{"key":"ref151","unstructured":"rccm.202411-2215OC"},{"key":"ref152","unstructured":"36. Fern\u00e1ndez P\u00e9rez ER, Travis WD, Lynch DA. Rethinking the CT and"},{"key":"ref153","unstructured":"Histopathological Nomenclature of Hypersensitivity Pneumonitis:"},{"key":"ref154","unstructured":"Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia."},{"key":"ref155","unstructured":"Am J Respir Crit Care Med. 2025;211(10):1738-1740. https:\/\/doi."},{"key":"ref156","unstructured":"org\/10.1164\/rccm.202505-1297ED"},{"key":"ref157","unstructured":"37. Huang YC, Gu JP. Impact of diagnostic guidelines on the"},{"key":"ref158","unstructured":"diagnosis of hypersensitivity pneumonitis. Front Med (Lausanne)."},{"key":"ref159","doi-asserted-by":"crossref","unstructured":"2023;10:1109525. https:\/\/doi.org\/10.3389\/fmed.2023.1109525","DOI":"10.3389\/fmed.2023.1109525"},{"key":"ref160","unstructured":"38. Buendia-Roldan I, Aguilar-Duran H, Johannson KA, Selman M."},{"key":"ref161","unstructured":"Comparing the Performance of Two Recommended Criteria for"},{"key":"ref162","unstructured":"Establishing a Diagnosis for Hypersensitivity Pneumonitis. Am J"},{"key":"ref163","unstructured":"Respir Crit Care Med. 2021;204(7):865-868. https:\/\/doi.org\/10.1164\/"},{"key":"ref164","unstructured":"rccm.202105-1091LE"},{"key":"ref165","unstructured":"39. Petnak T, Thongprayoon C, Baqir M, Ryu JH, Moua T. Antigen"},{"key":"ref166","unstructured":"identification and avoidance on outcomes in fibrotic hypersensitivity"},{"key":"ref167","doi-asserted-by":"crossref","unstructured":"pneumonitis. Eur Respir J. 2022;60(4):2101336. https:\/\/doi.","DOI":"10.1183\/13993003.01336-2021"},{"key":"ref168","unstructured":"org\/10.1183\/13993003.01336-2021"},{"key":"ref169","unstructured":"40. Kypreos M, Batra K, Glazer CS, Adams TN. Impact of number"},{"key":"ref170","unstructured":"and type of identified antigen on transplant-free survival in"},{"key":"ref171","doi-asserted-by":"crossref","unstructured":"hypersensitivity pneumonitis. PLoS One. 2022 1;17(9):e0273544.","DOI":"10.1371\/journal.pone.0273544"},{"key":"ref172","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1371\/journal.pone.0273544","DOI":"10.1371\/journal.pone.0273544"},{"key":"ref173","unstructured":"41. Barnes H, Corte TJ, Keir G, Khor YH, Limaye S, Wrobel JP, et al."},{"key":"ref174","unstructured":"Diagnosis and management of hypersensitivity pneumonitis in"},{"key":"ref175","unstructured":"adults: A position statement from the Thoracic Society of Australia"},{"key":"ref176","doi-asserted-by":"crossref","unstructured":"and New Zealand. Respirology. 2024;29(12):1023-1046. https:\/\/doi.","DOI":"10.1111\/resp.14847"},{"key":"ref177","unstructured":"org\/10.1111\/resp.14847"},{"key":"ref178","unstructured":"42. Kokkarinen JI, Tukiainen HO, Terho EO. Effect of corticosteroid"},{"key":"ref179","unstructured":"treatment on the recovery of pulmonary function in farmer\u2019s lung."},{"key":"ref180","doi-asserted-by":"crossref","unstructured":"Am Rev Respir Dis. 1992;145(1):3-5. https:\/\/doi.org\/10.1164\/","DOI":"10.1164\/ajrccm\/145.2_Pt_2.S1"},{"key":"ref181","unstructured":"ajrccm\/145.1.3"},{"key":"ref182","unstructured":"43. De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen"},{"key":"ref183","unstructured":"JA, Verbeken EK, et al. Effects of Corticosteroid Treatment and"},{"key":"ref184","unstructured":"Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort:"},{"key":"ref185","unstructured":"A Single-Centre Cohort Study. J Clin Med. 2018;8(1):14. https:\/\/doi."},{"key":"ref186","unstructured":"org\/10.3390\/jcm8010014"},{"key":"ref187","unstructured":"44. Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM,"},{"key":"ref188","unstructured":"Jones KD, et al. Use of Mycophenolate Mofetil or Azathioprine for"},{"key":"ref189","unstructured":"the Management of Chronic Hypersensitivity Pneumonitis. Chest."},{"key":"ref190","doi-asserted-by":"crossref","unstructured":"2017;151(3):619-625. https:\/\/doi.org\/10.1016\/j.chest.2016.10.029","DOI":"10.1016\/j.chest.2016.10.029"},{"key":"ref191","unstructured":"45. Adegunsoye A, Oldham JM, Fern\u00e1ndez P\u00e9rez ER, Hamblin M, Patel N,"},{"key":"ref192","unstructured":"Tener M, et al. Outcomes of immunosuppressive therapy in chronic"},{"key":"ref193","doi-asserted-by":"crossref","unstructured":"hypersensitivity pneumonitis. ERJ Open Res. 2017;3(3):00016-2017.","DOI":"10.1183\/23120541.00016-2017"},{"key":"ref194","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1183\/23120541.00016-2017","DOI":"10.1183\/23120541.00016-2017"},{"key":"ref195","unstructured":"46. Idiopathic Pulmonary Fibrosis Clinical Research Network; Raghu"},{"key":"ref196","unstructured":"G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ. Prednisone,"},{"key":"ref197","unstructured":"azathioprine, and N-acetylcysteine for pulmonary fibrosis. N"},{"key":"ref198","doi-asserted-by":"crossref","unstructured":"Engl J Med. 2012;366(21):1968-77. https:\/\/doi.org\/10.1056\/","DOI":"10.1056\/NEJMoa1113354"},{"key":"ref199","unstructured":"NEJMoa1113354"},{"key":"ref200","unstructured":"47. Ferreira M, Borie R, Crestani B, Rigaud P, Wemeau L, Israel-Biet"},{"key":"ref201","unstructured":"D, et al. Efficacy and safety of rituximab in patients with chronic"},{"key":"ref202","unstructured":"hypersensitivity pneumonitis (cHP): A retrospective, multicentric,"},{"key":"ref203","doi-asserted-by":"crossref","unstructured":"observational study. Respir Med. 2020;172:106146. https:\/\/doi.","DOI":"10.1016\/j.rmed.2020.106146"},{"key":"ref204","unstructured":"org\/10.1016\/j.rmed.2020.106146"},{"key":"ref205","unstructured":"48. Adegunsoye A, Morisset J, Newton CA, Oldham JM, Vittinghoff E,"},{"key":"ref206","unstructured":"Linderholm AL, et al. Leukocyte telomere length and mycophenolate"},{"key":"ref207","unstructured":"therapy in chronic hypersensitivity pneumonitis. Eur Respir J."},{"key":"ref208","doi-asserted-by":"crossref","unstructured":"2021;57(3):2002872. https:\/\/doi.org\/10.1183\/13993003.02872-2020","DOI":"10.1183\/13993003.02872-2020"},{"key":"ref209","unstructured":"49. Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, et"},{"key":"ref210","unstructured":"al. Telomere-related lung fibrosis is diagnostically heterogeneous but"},{"key":"ref211","doi-asserted-by":"crossref","unstructured":"uniformly progressive. Eur Respir J. 2016;48(6):1710-1720. https:\/\/","DOI":"10.1183\/13993003.00308-2016"},{"key":"ref212","unstructured":"doi.org\/10.1183\/13993003.00308-2016"},{"key":"ref213","unstructured":"50. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh"},{"key":"ref214","unstructured":"T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive"},{"key":"ref215","unstructured":"Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical"},{"key":"ref216","unstructured":"Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18-e47"},{"key":"ref217","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"ref218","unstructured":"51. Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, et al."},{"key":"ref219","unstructured":"Pirfenidone in patients with progressive fibrotic interstitial lung"},{"key":"ref220","unstructured":"diseases other than idiopathic pulmonary fibrosis (RELIEF): a doubleblind, randomised, placebo-controlled, phase 2b trial. Lancet Respir"},{"key":"ref221","unstructured":"Med. 2021;9(5):476-486"},{"key":"ref222","unstructured":"52. Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM,"},{"key":"ref223","unstructured":"Kreuter M, et al; FIBRONEER-ILD Trial Investigators. Nerandomilast"},{"key":"ref224","unstructured":"in Patients with Progressive Pulmonary Fibrosis. N Engl J Med."},{"key":"ref225","doi-asserted-by":"crossref","unstructured":"2025;392(22):2203-2214. https:\/\/doi.org\/10.1056\/NEJMoa2503643","DOI":"10.1056\/NEJMoa2503643"},{"key":"ref226","unstructured":"53. Jacobs SS, Krishnan JA, Lederer DJ, Ghazipura M, Hossain T, Tan"},{"key":"ref227","unstructured":"AM, et al. Home Oxygen Therapy for Adults with Chronic Lung"},{"key":"ref228","unstructured":"Disease. An Official American Thoracic Society Clinical Practice"},{"key":"ref229","unstructured":"Guideline. Am J Respir Crit Care Med. 2020;202(10):e121-e141."},{"key":"ref230","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1164\/rccm.202009-3608ST","DOI":"10.1164\/rccm.202009-3608ST"},{"key":"ref231","unstructured":"54. Dowman L, Hill CJ, May A, Holland AE. Pulmonary rehabilitation"},{"key":"ref232","unstructured":"for interstitial lung disease. Cochrane Database Syst Rev."},{"key":"ref233","doi-asserted-by":"crossref","unstructured":"2021;2(2):CD006322. https:\/\/doi.org\/10.1002\/14651858.CD006322.","DOI":"10.1002\/14651858.CD006322"},{"key":"ref234","unstructured":"pub4"},{"key":"ref235","unstructured":"55. Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa"},{"key":"ref236","unstructured":"M, et al. Consensus document for the selection of lung transplant"},{"key":"ref237","unstructured":"candidates: An update from the International Society for Heart and"},{"key":"ref238","unstructured":"Lung Transplantation. J Heart Lung Transplant. 2021;40(11):1349-"},{"key":"ref239","doi-asserted-by":"crossref","unstructured":"1379. https:\/\/doi.org\/10.1016\/j.healun.2021.07.005","DOI":"10.1016\/j.healun.2021.07.005"},{"key":"ref240","unstructured":"56. Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y,"},{"key":"ref241","unstructured":"et al. Palliative care in interstitial lung disease: living well. Lancet"},{"key":"ref242","unstructured":"Respir Med. 2017;5(12):968-980. https:\/\/doi.org\/10.1016\/S2213-"},{"key":"ref243","unstructured":"2600(17)30383-1"},{"key":"ref244","unstructured":"57. Ojanguren I, Morell F, Ram\u00f3n MA, Villar A, Romero C, Cruz MJ, et al."},{"key":"ref245","unstructured":"Long-term outcomes in chronic hypersensitivity pneumonitis. Allergy"},{"key":"ref246","doi-asserted-by":"crossref","unstructured":"2019;74(5):944-952. https:\/\/doi.org\/10.1111\/all.13692","DOI":"10.1111\/all.13692"},{"key":"ref247","unstructured":"58. Fern\u00e1ndez P\u00e9rez ER, Sprunger DB, Ratanawatkul P, Maier LA, Huie"},{"key":"ref248","unstructured":"TJ, Swigris JJ, et al. Increasing hypersensitivity pneumonitis-related"},{"key":"ref249","unstructured":"mortality in the United States from 1988 to 2016. Am J Respir"},{"key":"ref250","doi-asserted-by":"crossref","unstructured":"Crit Care Med 2019; 199(10):1284-1287. https:\/\/doi.org\/10.1164\/","DOI":"10.1164\/rccm.201807-1258LE"},{"key":"ref251","unstructured":"rccm.201807-1258LE"},{"key":"ref252","unstructured":"59. De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen"},{"key":"ref253","unstructured":"JA, Verbeken EK, et al. Impact of BAL lymphocytosis and presence"},{"key":"ref254","unstructured":"of honeycombing on corticosteroid treatment effect in fibrotic"},{"key":"ref255","unstructured":"hypersensitivity pneumonitis: a retrospective cohort study. Eur Respir"},{"key":"ref256","unstructured":"J. 2020; 55(4):1901983. https:\/\/doi.org\/10.1183\/13993003.01983-"},{"key":"ref257","unstructured":"2019"},{"key":"ref258","unstructured":"60. Chung JH, Zhan X, Cao M, Koelsch TL, Manjarres DCG, Brown"},{"key":"ref259","unstructured":"KK, et al. Presence of air trapping and mosaic attenuation on chest"},{"key":"ref260","unstructured":"computed tomography predicts survival in chronic hypersensitivity"},{"key":"ref261","doi-asserted-by":"crossref","unstructured":"pneumonitis. Ann Am Thorac Soc 2017;14(10):1533-1538. https:\/\/","DOI":"10.1513\/AnnalsATS.201701-035OC"},{"key":"ref262","unstructured":"doi.org\/10.1513\/AnnalsATS.201701-035OC"},{"key":"ref263","unstructured":"61. Simons IA, Korevaar DA, Denswil NP, Maitland-van der Zee"},{"key":"ref264","unstructured":"AH, Nossent EJ, Duitman JW; P4O2 consortium. Prognostic"},{"key":"ref265","unstructured":"biomarkers for the development of progressive pulmonary fibrosis in"},{"key":"ref266","unstructured":"hypersensitivity pneumonitis: a systematic review. Eur Respir Rev."},{"key":"ref267","doi-asserted-by":"crossref","unstructured":"2025;34(176):240282. https:\/\/doi.org\/10.1183\/16000617.0282-2024","DOI":"10.1183\/16000617.0282-2024"},{"key":"ref268","unstructured":"62. Katsaras M, Sotiropoulou V, Manali E, Fouka E, Papakosta D,"},{"key":"ref269","unstructured":"Bendstrup E, et al. Complete Blood Cell Count Parameters"},{"key":"ref270","unstructured":"Predict Mortality in Patients with Hypersensitivity Pneumonitis."},{"key":"ref271","unstructured":"Diagnostics (Basel). 2025;15(8):1038. https:\/\/doi.org\/10.3390\/"},{"key":"ref272","unstructured":"diagnostics15081038"},{"key":"ref273","unstructured":"63. Alqalyoobi S, Smith JA, Maddali MV, Pugashetti JV, Newton CA,"},{"key":"ref274","unstructured":"Kim JS, et al. Proteomic Biomarkers of Survival in Non-Idiopathic"},{"key":"ref275","unstructured":"Pulmonary Fibrosis Interstitial Lung Disease. Am J Respir Crit Care"},{"key":"ref276","unstructured":"Med. 2025;211(8):1452-1462. https:\/\/doi.org\/10.1164\/rccm.202407-"},{"key":"ref277","unstructured":"1506OC"},{"key":"ref278","unstructured":"64. W\u00e4lscher J, Gross B, Morisset J, Johannson KA, Vasakova M,"},{"key":"ref279","unstructured":"Bruhwyler J, et al. Comorbidities and survival in patients with chronic"},{"key":"ref280","unstructured":"hypersensitivity pneumonitis. Respir Res. 2020;21(1):12. https:\/\/doi."},{"key":"ref281","unstructured":"org\/10.1186\/s12931-020-1283-8"},{"key":"ref282","unstructured":"65. Oliveira RKF, Ota-Arakaki JS, Gomes PS, Gimenez A, Messina CMS,"},{"key":"ref283","unstructured":"Ramos RP, et al. Pulmonary haemodynamics and mortality in chronic"},{"key":"ref284","doi-asserted-by":"crossref","unstructured":"hypersensitivity pneumonitis. Eur Respir J. 2018;51(6):1800430","DOI":"10.1183\/13993003.00430-2018"},{"key":"ref285","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1183\/13993003.00430-2018","DOI":"10.1183\/13993003.00430-2018"},{"key":"ref286","unstructured":"66. Elnady MA, Elkorashy R, Nabil A, Ibrahim EK. Predictors of pulmonary"},{"key":"ref287","unstructured":"hypertension in patients with hypersensitivity pneumonitis. BMC"},{"key":"ref288","unstructured":"Pulm Med. 2023;23(1):61. https:\/\/doi.org\/10.1186\/s12890-023-"},{"key":"ref289","unstructured":"02347-1"},{"key":"ref290","unstructured":"67. Bridi GP, Freire da Silva B, Sobral-Alves JB, Carvalho CRF, Salge JM,"},{"key":"ref291","unstructured":"Alves-Jr JL, et al. Mechanisms of exercise limitation and prevalence"},{"key":"ref292","unstructured":"of pulmonary hypertension in hypersensitivity pneumonitis. ERJ"},{"key":"ref293","unstructured":"Open Res. 2025; in press"},{"key":"ref294","unstructured":"68. Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim"},{"key":"ref295","unstructured":"KG. Patients with fibrotic interstitial lung disease hospitalized for"},{"key":"ref296","unstructured":"acute respiratory worsening: a large cohort analysis. Chest 2016;"},{"key":"ref297","doi-asserted-by":"crossref","unstructured":"149(5):1205-1214 https:\/\/doi.org\/10.1016\/j.chest.2015.12.026","DOI":"10.1016\/j.chest.2015.12.026"},{"key":"ref298","unstructured":"69. Prior TS, W\u00e4lscher J, Gross B, Bendstrup E, Kreuter M. Clusters of"},{"key":"ref299","unstructured":"comorbidities in fibrotic hypersensitivity pneumonitis. Respir Res."},{"key":"ref300","doi-asserted-by":"crossref","unstructured":"2022;23(1):368. https:\/\/doi.org\/10.1186\/s12931-022-02291-4","DOI":"10.1186\/s12931-022-02291-4"},{"key":"ref301","unstructured":"70. Dack E, Christe A, Fontanellaz M, Brigato L, Heverhagen JT,"},{"key":"ref302","unstructured":"Peters AA, et al. Artificial Intelligence and Interstitial Lung Disease:"},{"key":"ref303","doi-asserted-by":"crossref","unstructured":"Diagnosis and Prognosis. Invest Radiol. 2023;58(8):602-609. https:\/\/","DOI":"10.1097\/RLI.0000000000000974"},{"key":"ref304","unstructured":"doi.org\/10.1097\/RLI.0000000000000974"},{"key":"ref305","unstructured":"71. Colligiani L, Marzi C, Uggenti V, Colantonio S, Tavanti L, Pistelli F,"},{"key":"ref306","unstructured":"et al. Unlocking the potential of radiomics in identifying fibrosing"},{"key":"ref307","unstructured":"and inflammatory patterns in interstitial lung disease. Radiol Med."},{"key":"ref308","unstructured":"2025;130(11):1797-1807. https:\/\/doi.org\/10.1007\/s11547-025-"},{"key":"ref309","unstructured":"02067-y"},{"key":"ref310","unstructured":"72. Bowman WS, Newton CA, Linderholm AL, Neely ML, Pugashetti JV,"},{"key":"ref311","unstructured":"Kaul B, et al. Proteomic biomarkers of progressive fibrosing interstitial"},{"key":"ref312","unstructured":"lung disease: a multicentre cohort analysis. Lancet Respir Med."},{"key":"ref313","doi-asserted-by":"crossref","unstructured":"2022;10(6):593-602. https:\/\/doi.org\/10.1016\/S2213-2600(21)00503-8","DOI":"10.1016\/S2213-2600(21)00503-8"},{"key":"ref314","unstructured":"73. Spagnolo P, Oldham JM, Jones MG, Lee JS. Personalized medicine"},{"key":"ref315","doi-asserted-by":"crossref","unstructured":"in interstitial lung diseases. Curr Opin Pulm Med. 2017;23(3):231-","DOI":"10.1097\/MCP.0000000000000370"},{"key":"ref316","doi-asserted-by":"crossref","unstructured":"236. https:\/\/doi.org\/10.1097\/MCP.0000000000000370","DOI":"10.1097\/MCP.0000000000000370"},{"key":"ref317","unstructured":"74. Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A,"},{"key":"ref318","unstructured":"Engel P, Bajwa A, et al. Inhaled Treprostinil in Pulmonary Hypertension"},{"key":"ref319","doi-asserted-by":"crossref","unstructured":"Due to Interstitial Lung Disease. N Engl J Med. 2021;384(4):325-334.","DOI":"10.1056\/NEJMoa2008470"},{"key":"ref320","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa2008470","DOI":"10.1056\/NEJMoa2008470"},{"key":"ref321","unstructured":"75. Yogeswaran A, Hassoun PM, Saleh K, F\u00fcnderich M, Balasubramanian"},{"key":"ref322","unstructured":"A, Konswa Z, et al. Hemodynamics and Phosphodiesterase-5 Inhibitor"},{"key":"ref323","unstructured":"Treatment Associated with Survival in ILD-PH: A PVRI GoDeep MetaRegistry Analysis. Am J Respir Crit Care Med. 2025;211(10):1855-"},{"key":"ref324","doi-asserted-by":"crossref","unstructured":"1866. https:\/\/doi.org\/10.1164\/rccm.202412-2371OC","DOI":"10.1164\/rccm.202412-2371OC"},{"key":"ref325","unstructured":"76. Figueiredo RG, Duarte NFV, Campos DCB, de Jesus Diaz Verduzco"},{"key":"ref326","unstructured":"M, M\u00e1rquez \u00c1A, de Araujo GTB, Rubin AS. Improving Accessibility"},{"key":"ref327","unstructured":"to Patients with Interstitial Lung Disease (ILD): Barriers to Early"},{"key":"ref328","unstructured":"Diagnosis and Timely Treatment in Latin America. Int J Environ Res"},{"key":"ref329","doi-asserted-by":"crossref","unstructured":"Public Health. 2024;21(5):647 https:\/\/doi.org\/10.3390\/ijerph21050647","DOI":"10.3390\/ijerph21050647"}],"container-title":["Respiratory Research &amp; Clinical Practice"],"original-title":[],"link":[{"URL":"https:\/\/www.ithenticate.com\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:40:55Z","timestamp":1774464055000},"score":1,"resource":{"primary":{"URL":"https:\/\/rrcpjournal.org\/article\/current-concepts-in-the-diagnosis-and-treatment-of-hypersensitivity-pneumonitis-a-narrative-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":330,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250394","relation":{},"ISSN":["3086-3910"],"issn-type":[{"value":"3086-3910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"2025-0394"}}